Intervention not reported
Diabetes‐related mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold
1 finding from 1 review
Secondary outcome: all adverse eventsTopical · adult patients with the common cold
1 finding from 1 review
Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold
3 findings from 1 review
no estimate extracted
3 studies · 146 participants
Moderate
no estimate extracted
2 studies · 85 participants
Low
no estimate extracted
1 study · 61 participants
GRADE not reported
Primary outcome: subjective symptom score (AUC) ‐ 3 hours after dosingOral · adult patients with the common cold
1 finding from 1 review
Outcomes relevant to participants' well‐being · adult patients with the common cold
1 finding from 1 review
Secondary outcome: all adverse events · adult patients with the common cold
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
General well‐being · adult patients with the common cold
1 finding from 1 review
Secondary outcome: all adverse events · adult patients with the common cold
1 finding from 1 review
Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold
3 findings from 1 review
no estimate extracted
2 studies · 94 participants
Low
no estimate extracted
1 study · 33 participants
GRADE not reported
no estimate extracted
1 study · 61 participants
GRADE not reported
Outcomes relevant to participants' well‐being · adult patients with the common cold
1 finding from 1 review
Secondary outcome: all adverse events · adult patients with the common cold
Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse events compared with placebo (low certainty).
1 finding from 1 review
Secondary outcome: all adverse eventsOral · adult patients with the common cold
Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse eventsOral compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Systolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Systolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawal due to adverse effects · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in systolic blood pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in diastolic blood pressure · Adults with primary hypertension
1 finding from 1 review